Irnocam 40MG Injection (5ml) is a chemotherapy medication that contains the active ingredient Irinotecan, which is primarily used in the treatment of various types of cancer, including colorectal cancer. This drug works by inhibiting the enzyme topoisomerase I, which is crucial for DNA replication and repair, thereby preventing cancer cells from dividing and growing. The injection is typically administered intravenously and is formulated to deliver a precise dose of 40mg of Irinotecan in a 5ml solution. Irnocam is often part of a combination therapy regimen, enhancing its effectiveness when used alongside other anticancer agents. Patients receiving Irnocam may experience a range of side effects, and it is essential for healthcare providers to monitor their condition closely during treatment. The drug’s composition and mechanism of action make it a vital option in the oncological therapeutic arsenal, aimed at improving patient outcomes in the fight against cancer.